HDAC9 and cancer: The results demonstrated that HDAC inhibitor+PI3K inhibitor combination therapy exerts more profound effects on the inhibition of cancer cell migration and invasion as compared to HDAC inhibitor or PI3K inhibitor alone (Table 3).